No connection

Search Results

Analysis Neutral

Merck Launches Tender Offer To Acquire Terns Pharmaceuticals

Apr 07, 2026 13:18 UTC

(RTTNews) - Merck & Co Inc. (MRK) said Tuesday it has commenced a cash tender offer to acquire all outstanding shares of Terns Pharmaceuticals, Inc. (TERN)..

  • April 07, 2026 — 09:18 am EDT Written byRTTNews
  • comforRTTNews-> (RTTNews) - Merck & Co Inc
  • (MRK) said Tuesday it has commenced a cash tender offer to acquire all outstanding shares of Terns Pharmaceuticals, Inc

April 07, 2026 — 09:18 am EDT Written byRTTNews.comforRTTNews-> (RTTNews) - Merck & Co Inc. (MRK) said Tuesday it has commenced a cash tender offer to acquire all outstanding shares of Terns Pharmaceuticals, Inc. (TERN). The move follows a definitive agreement announced on March 25, 2026, under which Merck agreed to acquire Terns. Under the terms of the tender offer, Terns shareholders will receive $53 per share in cash upon closing. Following completion of the offer, Terns will become a unit of Merck. The tender offer is set to expire on May 4, and the transaction is expected to close in the

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile